Correlation Between Evoke Pharma and American Airlines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and American Airlines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and American Airlines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and American Airlines Group, you can compare the effects of market volatilities on Evoke Pharma and American Airlines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of American Airlines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and American Airlines.

Diversification Opportunities for Evoke Pharma and American Airlines

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Evoke and American is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and American Airlines Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on American Airlines and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with American Airlines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of American Airlines has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and American Airlines go up and down completely randomly.

Pair Corralation between Evoke Pharma and American Airlines

Given the investment horizon of 90 days Evoke Pharma is expected to under-perform the American Airlines. In addition to that, Evoke Pharma is 2.27 times more volatile than American Airlines Group. It trades about -0.2 of its total potential returns per unit of risk. American Airlines Group is currently generating about -0.07 per unit of volatility. If you would invest  1,492  in American Airlines Group on January 25, 2024 and sell it today you would lose (69.00) from holding American Airlines Group or give up 4.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Evoke Pharma  vs.  American Airlines Group

 Performance 
       Timeline  
Evoke Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
American Airlines 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days American Airlines Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, American Airlines is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Evoke Pharma and American Airlines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evoke Pharma and American Airlines

The main advantage of trading using opposite Evoke Pharma and American Airlines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, American Airlines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in American Airlines will offset losses from the drop in American Airlines' long position.
The idea behind Evoke Pharma and American Airlines Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance